Poor adherence to staging guidelines for children with malignant ovarian tumors

详细信息    查看全文

• 作者：Arin L. Madenci^a ; ^b ; ^{amadenci@partners.org" class="auth_mail" title="E-mail the corresponding author} ; Bat-Sheva Levine^c ; Marc R. Laufer^d ; Theonia K. Boyd^e ; Stephan D. Voss^f ; A. Lindsay Frazier^g ; Christopher B. Weldon^b ; ^g
• 关键词：Oophorectomy ; Ovarian neoplasms ; Ovarian cysts ; Ovarian diseases ; Neoplasm staging ; Pediatrics
• 刊名：Journal of Pediatric Surgery
• 出版年：2016
• 出版时间：September 2016
• 年：2016
• 卷：51
• 期：9
• 页码：1513-1517
• 全文大小：202 K

文摘

Historically, surgical staging practices for pediatric malignant ovarian tumors mirrored adult guidelines. In 2004, the Children's Oncology Group (COG) developed guidelines specific to pediatric patients with ovarian germ cell tumors. We sought to characterize the operative management of pediatric ovarian lesions and adherence to COG surgical staging guidelines.

Methods

We conducted a single institution, retrospective study of pediatric patients who underwent surgical intervention for ovarian lesions between 1995 and 2012. The primary outcome was adherence to COG staging guidelines.

Results

Among 502 patients, 44 (8.8%) had malignant ovarian tumors. Two patients (2/44, 4.5%) underwent correct surgical staging. Therefore, 95.5% (42/44) underwent incorrect surgical staging by omitting recommended maneuvers (surgical understaging) or performing clinically unnecessary surgical staging steps (surgical overstaging). Of the 42 patients with incorrect surgical staging, 85.7% (36/42) were surgically overstaged and 76.2% (32/42) were surgically understaged. In the entire cohort, 12 (27.3%) patients had complete staging procedures, including 10 surgically overstaged patients (10/12, 83.3%). Staging practices were not significantly different before and after the release of the 2004 COG guidelines.

Conclusion

Incorrect surgical staging of pediatric ovarian malignancies is commonplace. These data stress the need for greater education among all surgeons caring for children with malignant ovarian tumors.